All news

Merck KGaA agrees to buy Rapid Micro Biosystems for $0.75 a share in cash

QuiverQuant · · AI-summarised by FinFlash

Merck KGaA, Darmstadt, Germany has agreed to acquire Rapid Micro Biosystems, maker of the Growth Direct automated microbial quality-control platform, for $0.75 per share in cash via a tender offer that has not yet started. The deal is expected to close in December 2026, subject to a minimum tender and customary conditions. Rapid Micro will join Merck KGaA's Life Science business after an 18-month partnership between the two firms. Perella Weinberg advised the target.

So What?

RPID shares should converge on the $0.75 offer; the bolt-on deepens Merck KGaA's bioprocessing and lab automation offering at a modest cost.

Read original source

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.